top of page

Consistent. Fast. Complete. 

Fluidx is redefining embolization with an easy-to-use and highly controllable ionic gel embolization platform, which will be used to treat a wide range of conditions including tumors, hemorrhage, and targeted neurovascular bleeds. 

Fluidx Medical Technology’s GPX Embolic is Featured on the Cover of the Journal of Interventional Radiology (JVIR)

  • On the cover, the distal reach of the GPX Embolic Device is highlighted by a striking cast in a pelvic tumor embolization

  • Results of the prospective, multi-center clinical trial are now published in JVIR

JVIRCover.jpg

Embolic Technologies

GPX Image.png
GPX Embolic Device Horiz.png

Peripheral distal embolic

ULTRA logo Horizontal tm.png

Peripheral embolics for hemorrhage and other applications

Impass Image.jpg
IMPASS logo horizontal tm.png

Neurovascular distal embolic

Latest Press

Interventional News Logo
Fluidx Medical announces first patient treated with novel embolic gel
03 April 2026
Endovascular Today Logo
Fluidx GPX Embolic Device Pivotal Trial Completes Enrollment
January 2026
Interventional News Logo
Fluidx Medical announces first patient treated in prospective trial
November 2024
Endovascular Today Logo
Fluidx Receives IDE Approval for Pivotal Trial of GPX Embolic Device
May 2024

Fluidx Medical’s GPX Embolic Device – durable liquid embolic

* Data on file. Fluidx Medical Technology, Inc.

The GPX Embolic Device, ULTRA Embolic Platform, and IMPASS Embolic Device are under development and do not have marketing clearance or approval in any market at this time. 

bottom of page